Transdermal Patch Market By Type (Drug-in-Adhesive, Matrix and Other Types) By Application (Pain Relief, Smoking Reduction and Cessation Aid, Overactive Bladder, Hormonal Therapy and Other Applications) By End Use (Homecare Setting, Hospitals and Clinics) By Region and Key Companies - Industry Segment Outlook, Market Assessment, Competition Scenario, Trends and Forecast 2024–2033

Published date: Feb 2024
Report ID: 15591
Number of Pages: 299
Format:

Fact Checked

Cite this Research

- 1. Transdermal Patch Market Introduction
  - 1.1. Definition
  - 1.2. Taxonomy
  - 1.3. Research Scope
- 2. Executive Summary
  - 2.1. Key Findings by Major Segments
  - 2.2. Top strategies by Major Players
- 3. Global Transdermal Patch Market Overview
  - 3.1. Transdermal Patch Market Dynamics
    
    3.1.1. Drivers
    
    3.1.2. Opportunities
    
    3.1.3. Restraints
    
    3.1.4. Challenges
  - 3.2. PESTLE Analysis
  - 3.3. Opportunity Map Analysis
  - 3.4. PORTER'S Five Forces Analysis
  - 3.5. Market Competition Scenario Analysis
  - 3.6. Product Life Cycle Analysis
  - 3.7. Opportunity Orbits
  - 3.8. Manufacturer Intensity Map
- 4. Global Transdermal Patch Market Value (US$ Mn), Share (%), and Growth Rate (%) Comparison by Type, 2012-2028
  - 4.1. Global Transdermal Patch Market Analysis by Type: Introduction
  - 4.2. Market Size and Forecast by Region
  - 4.3. Fentanyl Transdermal Patch
  - 4.4. Nicotine Transdermal Patch
  - 4.5. Buprenorphine Transdermal Patch
  - 4.6. Clonidine Transdermal Patch
  - 4.7. Oxybutynin Transdermal Patch
- 5. Global Transdermal Patch Market Value (US$ Mn), Share (%), and Growth Rate (%) Comparison by Application, 2012-2028
  - 5.1. Global Transdermal Patch Market Analysis by Application: Introduction
  - 5.2. Market Size and Forecast by Region
  - 5.3. The fentanyl transdermal system (patch) is used for the management of persistent, moderate to severe chronic pain in opioid-tolerant patients when a continuous, around-the-clock opioid analgesic is needed for an extended period of time.
  - 5.4. Nicotine skin patches are used to help people stop smoking cigarettes.
  - They provide a source of nicotine that reduces the withdrawal symptoms experienced when smoking is stopped.
  - 5.5. ApplictionC
  - 5.6. ApplictionD
  - 5.7. ApplictionE
- 6. Global Transdermal Patch Market Value (US$ Mn), Share (%), and Growth Rate (%) Comparison by Region, 2012-2028
  - 6.1. North America
    
    6.1.1. North America Transdermal Patch Market: Regional Trend Analysis
    
    6.1.1.1. US
    
    6.1.1.2. Canada
    
    6.1.1.3. Mexico
  - 6.2. Europe
    
    6.2.1. Europe Transdermal Patch Market: Regional Trend Analysis
    
    6.2.1.1. Germany
    
    6.2.1.2. France
    
    6.2.1.3. UK
    
    6.2.1.4. Russia
    
    6.2.1.5. Italy
    
    6.2.1.6. Rest of Europe
  - 6.3. Asia-Pacific
    
    6.3.1. Asia-Pacific Transdermal Patch Market: Regional Trend Analysis
    
    6.3.1.1. China
    
    6.3.1.2. Japan
    
    6.3.1.3. Korea
    
    6.3.1.4. India
    
    6.3.1.5. Rest of Asia
  - 6.4. Latin America
    
    6.4.1. Latin America Transdermal Patch Market: Regional Trend Analysis
    
    6.4.1.1. Brazil
    
    6.4.1.2. Argentina
    
    6.4.1.3. Rest of Latin America
  - 6.5. Middle East and Africa
    
    6.5.1. Middle East and Africa Transdermal Patch Market: Regional Trend Analysis
    
    6.5.1.1. GCC
    
    6.5.1.2. South Africa
    
    6.5.1.3. Israel
    
    6.5.1.4. Rest of MEA
- 7. Global Transdermal Patch Market Competitive Landscape, Market Share Analysis, and Company Profiles
  - 7.1. Market Share Analysis
  - 7.2. Company Profiles
  - 7.3. Hisamitsu Pharmaceutical
    
    7.3.1. Company Overview
    
    7.3.2. Financial Highlights
    
    7.3.3. Product Portfolio
    
    7.3.4. SWOT Analysis
    
    7.3.5. Key Strategies and Developments
  - 7.4. Novartis
    
    7.4.1. Company Overview
    
    7.4.2. Financial Highlights
    
    7.4.3. Product Portfolio
    
    7.4.4. SWOT Analysis
    
    7.4.5. Key Strategies and Developments
  - 7.5. Johnson & Johnson
    
    7.5.1. Company Overview
    
    7.5.2. Financial Highlights
    
    7.5.3. Product Portfolio
    
    7.5.4. SWOT Analysis
    
    7.5.5. Key Strategies and Developments
  - 7.6. Teikoku Pharma
    
    7.6.1. Company Overview
    
    7.6.2. Financial Highlights
    
    7.6.3. Product Portfolio
    
    7.6.4. SWOT Analysis
    
    7.6.5. Key Strategies and Developments
  - 7.7. Mylan
    
    7.7.1. Company Overview
    
    7.7.2. Financial Highlights
    
    7.7.3. Product Portfolio
    
    7.7.4. SWOT Analysis
    
    7.7.5. Key Strategies and Developments
  - 7.8. Actavis
    
    7.8.1. Company Overview
    
    7.8.2. Financial Highlights
    
    7.8.3. Product Portfolio
    
    7.8.4. SWOT Analysis
    
    7.8.5. Key Strategies and Developments
  - 7.9. Mundipharma
    
    7.9.1. Company Overview
    
    7.9.2. Financial Highlights
    
    7.9.3. Product Portfolio
    
    7.9.4. SWOT Analysis
    
    7.9.5. Key Strategies and Developments
  - 7.10. Henan Lingrui Pharmaceutical
    
    7.10.1. Company Overview
    
    7.10.2. Financial Highlights
    
    7.10.3. Product Portfolio
    
    7.10.4. SWOT Analysis
    
    7.10.5. Key Strategies and Developments
  - 7.11. Changzhou Siyao
    
    7.11.1. Company Overview
    
    7.11.2. Financial Highlights
    
    7.11.3. Product Portfolio
    
    7.11.4. SWOT Analysis
    
    7.11.5. Key Strategies and Developments
  - 7.12. Rfl Pharmaceutical
    
    7.12.1. Company Overview
    
    7.12.2. Financial Highlights
    
    7.12.3. Product Portfolio
    
    7.12.4. SWOT Analysis
    
    7.12.5. Key Strategies and Developments
- 8. Assumptions and Acronyms
- 9. Research Methodology
- 10. Contact
- Hisamitsu Pharmaceutical
- Novartis
- Johnson & Johnson
- Teikoku Pharma
- Mylan
- Actavis
- Mundipharma
- Henan Lingrui Pharmaceutical
- Changzhou Siyao
- Rfl Pharmaceutical
- AdhexPharma
- ProSolus, Inc
- Tapemark
- Tesa Tapes (India) Pvt. Ltd.
- Nitto Denko Corporation.
- Noven Pharmaceuticals, Inc
- LTS Lohmann Therapie-Systeme AG
- Medherant Limited
- Corium, Inc.
- Bayer AG
- Other Key Players